ARCHIVES

House-Senate Conferees agree On NCI Total for FY’89, Then Cut It $19 Million

This article is from The Cancer Letter archive.

Vol. 14 No. 35 | August 26, 1988

Download PDF Visit The Full Archive

Related Articles

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013

Stand Up To Cancer Launches Immunology “Dream Team”

December 14, 2012

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

NCI Advisory Group, Other Cancer Meetings

April 29, 1983

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979

NCI Staff Will Recommend That Comprehensive Recognition Be Withdrawn From Colorado Center

October 31, 1980